London

Resilience System

Main menu


You are here

United States

Vaccine by Nov. 3? Halted study explains just how unlikely

WASHINGTON (AP) — The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Global death toll from the coronavirus has surpassed 900,000--NYTimes roundup

The global death toll from the coronavirus has surpassed 900,000, according to a New York Times database, and sickened at least 27.8 million people as of Thursday morning.

Seven months into the pandemic, the virus has been detected in almost every country.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Why COVID-19 is more deadly in people with obesity—even if they're young

Since the pandemic began, dozens of studies have reported that many of the sickest COVID-19 patients have been people with obesity. In recent weeks, that link has come into sharper focus as large new population studies have cemented the association and demonstrated that even people who are merely overweight are at higher risk.

Problem, Solution, SitRep, or ?: 

White House orders end to COVID-19 airport screenings for international travelers--Yahoo exclusive

WASHINGTON — The U.S. government on Monday will stop conducting enhanced screening of passengers on inbound international flights for COVID-19, Yahoo News has learned. 

The screening operations have been held at select airports since January, when the first cases of the disease began to emerge from Wuhan, China. Since March, incoming international flights from select high-risk countries, including much of Europe, China and Iran, among other regions, have been funneled through 15 designated airports in the United States.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

WHO says vaccine safety top priority, as AstraZeneca pauses study

ZURICH/GENEVA (Reuters) - Safety of a prospective COVID-19 vaccine comes "first and foremost", the World Health Organization's chief scientist said on Wednesday, as a trial of a leading candidate from AstraZeneca was paused due to concerns over side effects.

Rollout of an effective vaccine is seen as a crucial step in helping battered economies recover from the coronavirus pandemic.

"Just because we talk about speed...it doesn't mean we start compromising or cutting corners on what would normally be assessed," Dr. Soumya Swaminathan said in a social media event.

"The process still has to follow through rules of the game. For drugs and vaccines which are given to people, you have to test their safety, first and foremost," she said.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to United States
howdy folks